Xenova Group plc of Oxford, England, appointed GeoffreyMcMillan commercial director and a member of the board ofdirectors. McMillan was head of business development andplanning for the international pharmaceutical division of F.Hoffmann-La Roche Ltd. in the United Kingdom andSwitzerland. Also named to the board were SteliosPapadopoulos, a managing director and head of the healthcare/life sciences investment banking group at PaineWebberInc.; and Louis Lavigne Jr., chief financial officer at GenentechInc.
Zynaxis Inc. of Malvern, Pa., promoted Katherine Muirhead tosenior vice president of research from vice president ofresearch.
Cypros Pharmaceutical Corp. of San Diego appointed MichaelLockey vice president, regulatory development. Lockey hadbeen the general manager of Synergia, a California consultingorganization specializing in the clinical and regulatorydevelopment of health care products. Cypros also promotedHoward Jones from vice president to senior vice president,durg development.
(c) 1997 American Health Consultants. All rights reserved.